Enterovirus A71 antivirals: Past, present, and future
Enterovirus A71 (EV-A71) is a significant human pathogen, especially in children. EV-A71 infection is one of the leading causes of hand, foot, and mouth diseases (HFMD), and can lead to neurological complications such as acute flaccid myelitis (AFM) in severe cases. Although three EV-A71 vaccines ar...
Main Authors: | Jun Wang, Yanmei Hu, Madeleine Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383521003075 |
Similar Items
-
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
by: Salima Lalani, et al.
Published: (2021-08-01) -
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Salima S. Lalani, et al.
Published: (2020-03-01) -
Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01) -
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
by: Qunying Mao, et al.
Published: (2016-01-01) -
A prospective, comparative study of severe neurological and uncomplicated hand, foot and mouth forms of paediatric enterovirus 71 infections
by: Yoann Crabol, et al.
Published: (2017-06-01)